• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中的影像学生物标志物:¹⁸F-FDG PET/CT的作用

Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT.

作者信息

Mapelli Paola, Incerti Elena, Fallanca Federico, Gianolli Luigi, Picchio Maria

机构信息

Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy -

出版信息

Q J Nucl Med Mol Imaging. 2016 Jun;60(2):93-102. Epub 2016 Feb 9.

PMID:26859083
Abstract

Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.

摘要

卵巢癌是西方世界女性主要的癌症形式之一,其隐匿性导致许多患者在晚期才出现临床表现。因此,成像技术对于这些患者的正确管理非常重要。在本综述中,介绍了18F-FDG-PET/CT在不同临床环境中的作用,并讨论了其与其他成像方式和血清生物标志物CA-125的比较。

相似文献

1
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT.卵巢癌中的影像学生物标志物:¹⁸F-FDG PET/CT的作用
Q J Nucl Med Mol Imaging. 2016 Jun;60(2):93-102. Epub 2016 Feb 9.
2
Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer.氟脱氧葡萄糖F 18正电子发射断层显像/计算机断层扫描对卵巢癌的评估
PET Clin. 2018 Apr;13(2):179-202. doi: 10.1016/j.cpet.2017.11.005. Epub 2018 Jan 10.
3
Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.采用 2-[F-18]氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描技术对血清 CA-125 水平轻度升高的患者进行复发性卵巢癌的早期检测。
Cancer Biother Radiopharm. 2011 Apr;26(2):175-81. doi: 10.1089/cbr.2010.0872. Epub 2011 Apr 21.
4
Management of epithelial ovarian cancer from diagnosis to restaging: an overview of the role of imaging techniques with particular regard to the contribution of 18F-FDG PET/CT.上皮性卵巢癌从诊断到再分期的管理:影像技术作用概述,尤其关注18F-FDG PET/CT的贡献
Nucl Med Commun. 2014 Jun;35(6):588-97. doi: 10.1097/MNM.0000000000000091.
5
An update on the role of PET/CT and PET/MRI in ovarian cancer.正电子发射断层扫描/计算机断层扫描(PET/CT)和正电子发射断层扫描/磁共振成像(PET/MRI)在卵巢癌中作用的最新进展。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1079-1091. doi: 10.1007/s00259-017-3638-z. Epub 2017 Feb 8.
6
FDG-PET/CT as a molecular biomarker in ovarian cancer.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为卵巢癌的分子生物标志物。
Cancer Biomark. 2010;8(4-5):167-75. doi: 10.3233/CBM-2011-0219.
7
The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在肿瘤标志物升高或增强CT有可疑病变的卵巢癌患者复发评估和/或腹内转移判定中的作用。
Rev Esp Med Nucl Imagen Mol. 2012 Jan-Feb;31(1):3-8. doi: 10.1016/j.remn.2011.03.008. Epub 2011 May 6.
8
Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.与对比增强CT和肿瘤标志物Ca-125相比,18F-FDG PET/CT在卵巢癌患者再分期中诊断腹膜癌转移的作用。
Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):22-7. doi: 10.1016/j.remn.2013.06.008. Epub 2013 Aug 13.
9
Malignant ovarian Brenner tumor. A case report evaluated with (18)F-FDG PET/CT.恶性卵巢布伦纳瘤。18F-FDG PET/CT评估的病例报告。
Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):337-8. doi: 10.1016/j.remn.2015.03.001. Epub 2015 Apr 15.
10
[PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].[利用(18)F-FDG进行PET/CT扫描对一例非典型卵巢癌病例进行再分期]
Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):223-4. doi: 10.1016/j.remn.2011.09.002. Epub 2011 Nov 4.

引用本文的文献

1
Application of single cell sequencing technology in ovarian cancer research (review).单细胞测序技术在卵巢癌研究中的应用(综述)。
Funct Integr Genomics. 2024 Aug 28;24(5):144. doi: 10.1007/s10142-024-01432-w.
2
The value of combined MRI, enhanced CT and F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.联合 MRI、增强 CT 和 F-FDG PET/CT 在卵巢癌手术后复发和转移诊断中的价值。
Clin Transl Oncol. 2024 Dec;26(12):3013-3019. doi: 10.1007/s12094-024-03499-0. Epub 2024 May 23.
3
Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model.
卵巢癌的早期诊断:血清人附睾蛋白4、癌抗原125及ROMA模型
Am J Transl Res. 2021 Dec 15;13(12):14141-14148. eCollection 2021.
4
Role of blood oxygenation saturation in ovarian cancer diagnosis using multi-spectral photoacoustic tomography.多光谱光声断层扫描中血氧饱和度在卵巢癌诊断中的作用。
J Biophotonics. 2021 Apr;14(4):e202000368. doi: 10.1002/jbio.202000368. Epub 2021 Jan 6.
5
A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma.一种五基因表达特征可预测卵巢浆液性囊腺癌的临床结局。
Biomed Res Int. 2016;2016:6945304. doi: 10.1155/2016/6945304. Epub 2016 Jul 5.